Cellectar Biosciences, Inc. (CLRB) income statement
CLRBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.80−0.09 (-9.73%)
Close on Nov 20, 2026Market cap $7.53MP/E –Yield –
Cellectar Biosciences, Inc. financial ratios
See a number that looks wrong?